Ambient Biosciences
Ambient Biosciences is a global leader in biostabilization, dedicated to eliminating cold chain reliance and improving global health equity through innovative biomolecule stabilization technology. Their patented Capillary-Assisted Vitrification (CAV) process enables room-temperature storage and shipping of sensitive reagents and biomolecules, offering a superior alternative to traditional lyophilization and cryopreservation. With a values-driven, diverse team of scientific experts and visionary leaders, Ambient Biosciences is committed to transforming laboratory operations, reducing costs and waste, and making life sciences more accessible and sustainable worldwide.
Ambient Biosciences
1600 Huron Parkway, Bldg 520, Rm 2390, Ann Arbor, MI 48109
Patents
What We Do
A compact, benchtop instrument that enables rapid, room-temperature stabilization of a wide range of biomolecules in under 2 hours. Designed for easy integration into research workflows or manufacturing lines, requiring minimal optimization and no specialized training.
Shelf-stable reagents dried on tABs (thermostable assay beads), including Streptavidin Horseradish Peroxidase (HRP) Conjugate, Streptavidin Alkaline Phosphatase (AP) Conjugate, and Streptavidin Allophycocyanin (APC), for use in ELISA, IHC, IF, FCM, and FACS applications.
A proprietary stabilization process that eliminates the need for freezing, enabling ambient storage and shipping of antibodies, enzymes, DNA/RNA, small molecules, cells, and master mixes. The process is rapid, gentle, and broadly applicable across biomolecule classes.
Outsource your biomolecule stabilization to Ambient Bio and receive packaged shelf-stable products ready to reconstitute or ship. The company offers collaborative development, rapid turnaround, and cost-effective solutions for both small and large-scale projects.
Ambient Biosciences provides comprehensive technical consultation to accelerate validation and get products to market faster, including personalized installation and ongoing support for their stabilization technology.
Special academic pricing and support for universities and research institutions to implement the Ambient Stabilizer in their labs, including on-site installation, monthly consumables, and technical support.
Infectious Diseases
Services
Key People
Founder and Chief Innovation Officer
News & Updates
Ambient Biosciences holds patents for their Capillary-Assisted Vitrification (CAV) process, ensuring biomolecules retain activity after years of room temperature storage and enabling extended shelf life.
Ambient Biosciences has successfully partnered with organizations such as B2S Life Sciences, Vanderbilt University, AssayQuant Technologies, and Ambry Genetics to validate and apply their stabilization technology in real-world settings.
Study exploring CAV as an alternative to lyophilization for vaccine stabilization, showing comparable immunogenicity and quality, and confirming broad compatibility and thermostability benefits.
Case study with B2S Life Sciences demonstrating successful stabilization of antibodies for ambient storage, preserving molecular integrity and functionality.
Press release announcing the Early Access Program for partners to trial CAV technology, reducing cold storage reliance and extending shelf life.
Research report supporting CMV as a viable alternative to frozen reagent storage, with significant impact on reagent stability, assay performance, and sustainability.
Research demonstrating that PCR master mixes processed with CMV maintain performance after storage at 37°C, enabling room temperature storage.
Study showing that CMV technology improves Lipofectamine transfection efficiency and maintains reagent activity under stress conditions.
Research showing that CMV enables ambient storage of kinase assay reagents, maintaining enzymatic activity and simplifying global distribution.
Spotlight article in GEN highlighting Ambient Biosciences' ambient temperature-stable products as a manufacturing-ready technology for convenience, profitability, and sustainability.
Study demonstrating that CMV can store antibodies in a thermostable, single-use format at elevated temperatures, simplifying workflows and reducing waste.
Collaboration with Promega showing that CMV preserves luciferin, luciferase, and related reagents for luminescence assays, even after high temperature exposure.
Study highlighting CMV's benefits in stabilizing luminescence reagents, allowing ambient storage and maintaining performance.
Comparison study showing that CMV offers comparable thermal stability to lyophilization with reduced cycle times and lower costs.
Research showing that CMV stabilizes biomolecules at room temperature, reducing costs and environmental impact.
Study showing that CMV enhances stability and performance of various bioassay reagents, reducing cold chain reliance.
Research demonstrating that CMV preserves antibodies, enzymes, and mRNA at elevated temperatures, reducing the need for cold storage.
Spotlight article in BIOMATTERS discussing the global impact of cold chain logistics and how Ambient Biosciences' technology addresses these challenges.
Capillary-Mediated Vitrification: A Novel Approach for Preparing Thermostable, Ready-to-Use Reagents
ACS report demonstrating the stability and performance of CMV-stabilized reagents as a promising alternative to traditional biopreservation.
AAPS Journal article showing that CMV significantly enhances the thermal stability of mRNA, enabling storage at high temperatures.
Journal of Pharmaceutical Sciences article demonstrating that CMV produces an amorphous dried product with enhanced thermal stability, as shown with luciferase.
A new case study highlighting the application and benefits of Ambient Biosciences' stabilization technology, available for download.